As of 2025-12-16, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -18.35 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.82 USD, the upside of Cullinan Oncology Inc is -269.59%.
Based on its market price of 10.82 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 269.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.35 - -18.35 | -18.35 | -269.59% |
| P/E | (77.58) - (86.09) | (87.62) | -909.8% |
| DDM - Stable | (18.95) - (47.37) | (33.16) | -406.5% |
| DDM - Multi | (12.68) - (25.34) | (16.97) | -256.9% |
| Market Cap (mil) | 639.25 |
| Beta | 0.71 |
| Outstanding shares (mil) | 59.08 |
| Enterprise Value (mil) | 535.91 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.26% |
| Cost of Debt | 5.00% |
| WACC | 9.59% |